← Open Payments lookup

SANDRA BREMNER-DEXTER: Open Payments

NPI 1386709012 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$332 in 15 payments from 10 companies in 2025. Trend: 2023 $1,486 · 2024 $1,115 · 2025 $332

Food & beverage: $332
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.3$71
Janssen Pharmaceuticals, Inc2$70
Otsuka America Pharmaceutical, Inc.2$39
Lundbeck LLC2$35
Neurocrine BioSciences, Inc.1$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Alkermes, Inc.1$18
Takeda Pharmaceuticals U.S.A., Inc.1$16
Collegium Pharmaceutical, Inc.1$15
E.R. Squibb & Sons, L.L.C.1$15

Products named: REXULTI, AUSTEDO XR, SPRAVATO, INGREZZA, CAPLYTA, INVEGA SUSTENNA, LYBALVI, UZEDY.

Industry payments across WA — which companies pay providers there.